logo

Novartis Ag (NVS)



Trade NVS now with
  Date
  Headline
2/1/2023 1:02:17 AM Novartis Q4 EPS $0.69; Core EPS $1.52
1/9/2023 9:06:53 AM Royalty Pharma Acquires Interest In Ionis' Royalty In Biogen's SPINRAZA &Novartis' Pelacarsen For Up To $1.125 Bln
12/13/2022 10:05:21 AM Novartis Presents Phase III Data Demonstrating Oral Monotherapy Iptacopan Superiority Over Anti-C5
12/8/2022 1:29:58 AM Novartis Says Phase III APPOINT-PNH Study Of Oral Monotherapy Iptacopan Meets Primary Endpoint
12/5/2022 1:36:11 AM Novartis Says Phase III PSMAfore Study With PluvictoTM Meets Primary Endpoint
11/30/2022 10:14:03 AM Novartis Says On Track To Achieve 2025 Targets
10/25/2022 1:03:55 AM Novartis Q3 EPS $0.73; Core EPS $1.58
10/24/2022 1:40:23 AM Novartis Says Phase III APPLY-PNH Trial Meets Two Primary Endpoints For Superiority Over Anti-C5 Treatment